Combination products; integrating drugs, devices, and biologics, are among the most complex innovations in modern healthcare. They promise significant benefits for patients by delivering convenience, safety, and effectiveness in one package. But with this promise comes heightened regulatory scrutiny, intricate development challenges, and the need for strong systems to manage risk.
At the heart of navigating these challenges is traceability. Far more than an industry buzzword, traceability is the connective tissue that links requirements, design controls, verification, validation, and post-market feedback into a coherent system of evidence. For organizations developing combination products, traceability is essential not only for regulatory compliance, but also for ensuring product quality, patient safety, and organizational efficiency.
This blog explores how traceability serves as the backbone of combination product development.
Why Traceability Matters in Combination Products
Developing a traditional medical device or pharmaceutical product is complex enough in its own right. However, when the two (or more) are combined into a single product; such as a drug-eluting stent, prefilled injector, or digital therapeutic, the complexity multiplies. Each component brings its own regulatory framework, standards, and risk profile.
Traceability provides a way to manage this complexity by ensuring that:
- Every requirement is linked to design inputs and outputs.
- Every test can be traced back to the requirement it verifies or validates.
- Every change is recorded, assessed for impact, and linked to downstream and upstream artifacts.
- Every complaint or adverse event can be traced back to its root cause in design or manufacturing.
Without this infrastructure teams risk silos, missed dependencies, and incomplete submissions- leading to delays, audit findings, or worse, patient safety risks.
Traceability as the key to Verification & Validation
Verification and validation (V&V) are among the most critical stages in combination product development. Verification ensures that design outputs meet the specified requirements, while validation confirms that the product meets user needs and intended uses. For combination products, both device and drug elements must be verified and validated, often under different regulatory paradigms.
The Challenge of V&V in Combination Products
- Multiple Standards: Device verification may be guided by IEC standards, while pharmaceutical validation may follow ICH or USP guidelines. Both must be harmonized in the context of a single product.
- Integrated Testing: In many cases, tests must be performed on the integrated product (e.g., ensuring that a prefilled injector consistently delivers the correct dose).
- Complex Test Plans: With overlapping requirements, tests often serve multiple verification objectives, requiring careful mapping.
How Traceability Helps Mitigate These Challenges
- Requirements Coverage – Every requirement should have at least one linked test. Traceability ensures no requirement goes unverified, and no test exists without a clear purpose.
- Risk-Based Testing – High-risk requirements (e.g., those linked to patient safety or efficacy) can be prioritized for more rigorous or redundant testing. Traceability connects risks, requirements, and tests- making risk-based testing practical and efficient.
- Change Impact Analysis – If a requirement changes late in development, traceability makes it clear which tests must be repeated or updated, saving time and reducing the risk of overlooked dependencies.
- Test Plan Integrity – Traceability supports the creation of integrated test plans that cover both drug and device aspects, ensuring that the product as a whole has been comprehensively evaluated.
Why Auditors Ask for Your Traceability Matrix First
Audits are a fact of life for combination product manufacturers. Regulatory bodies like the FDA, or MDR demand evidence that a manufacturer has controlled its development process, implemented risk management, and adhered to applicable regulations (21 CFR Part 4, ISO 13485, ISO 14971, ICH Q10, and others).
The Auditor’s Lens
When auditors arrive, they often begin by asking for traceability matrices, documents, or system outputs that show the end-to-end connections between requirements, risks, design outputs, and verification activities. Their goal is to confirm that the product was developed in a structured, compliant, and controlled manner.
For combination products, auditors may look for:
- Evidence that drug and device regulations were both considered.
- Traceability between drug master file (DMF) references, device design controls, and combination-specific requirements.
- Proof that risk mitigations were implemented and tested.
- Clear linkage between user needs, design inputs, and verification and validation results.
A robust traceability system ensures that organizations can respond to auditors’ questions quickly and confidently. With a robust system, teams can generate on-demand traceability reports—demonstrating both compliance and organizational maturity.
On-Market Support and Complaint Management
Traceability doesn’t stop at launch, it becomes even more critical once real-world data begins to flow in. Complaints, adverse events, and product performance reports are valuable feedback loops but only if they can be connected back to the design and manufacturing processes.
Combination products can generate complaints from multiple angles:
- Drug-related issues, such as stability, efficacy, or adverse reactions.
- Device-related issues, such as malfunctions, usability problems, or sterility breaches.
- Interface issues, where the drug and device components interact poorly (e.g., a delivery device that fails to deliver the intended dosage).
Benefits of Traceability in Post-Market Surveillance
- Faster Root Cause Analysis – By tracing complaints back through the requirements and risk structure, teams can more quickly determine whether an issue is isolated or systemic. Additionally, teams can quickly determine linkages to the following risk items:
- Product requirements and design history file (DHF) elements.
- Product family or platform risk management documentation.
- Manufacturing records and batch data.
- Verification or validation test results related to the specific reported issue.
- Regulatory Reporting Confidence – When regulators request complaint investigations or post-market surveillance reports, traceability provides documented evidence to demonstrate compliance.
- Continuous Improvement – Complaints can feed back into updated requirements, new test cases, or revised risk assessments, closing the loop and strengthening the product lifecycle.
- Lifecycle Management: As combination products are updated, reformulated, or adapted for new markets, traceability provides the backbone for controlled evolution.
Traceability has the potential to transform post-market chaos into a structured process for learning and improvement.
Additional Benefits of Traceability in Combination Product Development
Beyond the areas of audits, complaint management, and V&V, traceability delivers a host of other benefits:
- Cross-Functional Alignment: With traceability tools, pharmaceutical scientists, device engineers, and quality professionals can collaborate more effectively, breaking down silos.
- Efficient Documentation: Regulatory submissions for combination products often require extensive documentation. Traceability systems can generate much of this automatically and reduce redundances.
- Reduced Development Risk: By ensuring that all requirements, risks, and tests are accounted for, traceability reduces the chance of late-stage surprises.
Making Traceability Part of Your DNA
Implementing traceability is not just about software or documentation—it’s about culture. Organizations must embed traceability into their development DNA, ensuring that every team member understands the importance of linking their work to the bigger picture.
Practical Steps to Build Traceability
- Define Clear Processes – Establish how requirements, risks, design outputs, and tests should be documented and linked.
- Adopt Supporting Tools – Spreadsheets may work for small projects, but modern combination product development often demands specialized requirements and traceability management platforms.
- Train Teams – Ensure that all stakeholders, from R&D to quality to regulatory affairs, understand how to apply traceability in their daily work.
- Measure and Improve – Track traceability metrics, such as requirements coverage or test completion, to drive continuous improvement.
By building traceability into both processes and culture, organizations set themselves up for long-term success.
Conclusion
Combination products are at the frontier of medical innovation, but they also bring unprecedented complexity. In this environment, traceability is not optional—it is essential.
Through traceability, organizations can:
- Face audits with confidence, armed with complete and accurate evidence.
- Manage post-market complaints effectively, ensuring patient safety and regulatory compliance.
- Prepare for verification and validation with structured, risk-based test plans that cover every requirement.
Most importantly, traceability helps ensure that combination products are safe, effective, and reliable for the patients who depend on them. When seen as a strategic enabler- not a regulatory burden- traceability turns compliance into competitive advantage and ensures safer, more effective products for patients..
At Ventura Solutions, we help medical device and combination product companies succeed across every stage of development. Whether you need end-to-end support with an integrated device team, quality or regulatory consulting, assistance with DHF remediation, additional staffing needs, employee training, or more; our team of experts are ready to help. Contact us today.
Interested in learning more about medical device and combination product development? Subscribe to our newsletter below for expert insights, the latest developments in medical device and combination product space, and exciting career opportunities!
